Cabaletta Bio
Cabaletta Bio is a biopharmaceutical company that researches and develops T cell-based therapeutics for the treatment of autoimmune diseases.
Business Model:
Revenue: $0
Employees: 51-200
Industries / Tags:
Detailed Cabaletta Bio Information
Geographic Data
Address: 2929 Arch Street
City: Philadelphia
State: PA
Zip: 19104
Country: US
Financial Info
Stage:
series b
Raised Last:
$50M
Raised Total:$88M
Social
Metrics
2,325,622Website Global Rank
8,050Website Monthly Traffic
Twitter Followers
Description
Cabaletta Bio is a biopharmaceutical company that researches and develops T cell-based therapeutics for the treatment of autoimmune diseases.
Contact Phone:
+12677593100
Contact Email:
Cabaletta Bio went public on 10/24/2019 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
10/24/2019
IPO Valuation:
$258M
Ticker Symbol:
CABA
IPO Price:
$11/share
Amount Raised:
$75M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
